Late form of Pompe disease with glycogen storage in peripheral nerves axons

J Neurol Sci. 2011 Feb 15;301(1-2):59-62. doi: 10.1016/j.jns.2010.10.031. Epub 2010 Nov 25.

Abstract

Pompe disease is caused by the deficiency of acid α-glucosidase (GAA), which degrades glycogen into glucose. Its manifestation is characterized by a broad and continuous spectrum of clinical severity ranging from severe infantile to relatively benign adult form. We describe a 12-year-old girl diagnosed at a presymptomatic stage of late form Pompe disease due to fortuitous detection of an elevated level of serum creatine kinase (CK) at the age of 4. Biopsies were taken from the quadriceps muscle and studied with histological and histochemical techniques, as well as in electron microscope. Sporadic muscle cells showed the accumulation of lysosomal glycogen, suggesting Pompe disease. Interestingly, we found lysosomal bound glycogen, located in the axons of intramuscular nerves. The diagnosis was confirmed by deficient GAA activity in leukocytes. Mutation analysis revealed changes IVS1-13T>G and p.C103G in the GAA gene. The patient was able to obtain enzyme replacement therapy in the early asymptomatic stage of the disease.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Asymptomatic Diseases
  • Axons / chemistry
  • Axons / pathology
  • Child
  • Enzyme Replacement Therapy
  • Female
  • Glycogen / analysis*
  • Glycogen Storage Disease Type II / drug therapy
  • Glycogen Storage Disease Type II / epidemiology
  • Glycogen Storage Disease Type II / pathology*
  • Heterozygote
  • Humans
  • Leukocytes / enzymology
  • Lysosomes / chemistry
  • Lysosomes / ultrastructure
  • Microscopy, Electron
  • Muscle, Skeletal / innervation
  • Muscle, Skeletal / ultrastructure
  • Mutation, Missense
  • Peripheral Nerves / chemistry*
  • Peripheral Nerves / pathology
  • Staining and Labeling
  • Vacuoles / ultrastructure
  • alpha-Glucosidases / analysis
  • alpha-Glucosidases / deficiency
  • alpha-Glucosidases / genetics
  • alpha-Glucosidases / therapeutic use

Substances

  • Glycogen
  • GAA protein, human
  • alpha-Glucosidases